Mumbai, Nov. 14 -- Profit before tax (PBT) rose 68.9% YoY to Rs 232.52 crore in Q2 FY26. EBITDA jumped 62.66% to Rs 257 crore, with EBITDA margin improved 16.6% during the quarter. For the first half... Read More
Mumbai, Nov. 14 -- Aurobindo Pharma has received the Establishment Inspection Report (EIR) issued by the USFDA classifying Unit 1 of Apitoria Pharma, a wholly owned subsidiary of the company as 'Volun... Read More